← Back to browse
Advancing innovation in accelerated cancer diagnosis
Innovate UK
Award
Amount not published
Total fund Up to £25.4m
Deadline
Closes 28 October 2026
Opens 1 September 2026
Where
UK-wide
Summary
Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
Who can apply
This competition is open to collaborations only. To lead a collaborative project your organisation must be a UK registered business of any size, an academic institution or an NHS organisation. The consortium must contain at least one UK registered micro, small or medium sized enterprise (SME) claiming grant funding on this application.